60 mg QD Alogabat ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
201	Angelman syndrome	1

201. Angelman syndrome

Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05630066 (ClinicalTrials.gov)	June 1, 2023	9/11/2022	Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat i ...	A Phase IIa Multicenter, Open-Label, 12-Week Study to Investigate the Pharmacokinetics and Safety an ...	Angelman Syndrome	Drug: 60 mg QD Alogabat;Drug: 40 mg QD Alogabat;Drug: 7 mg QD Alogabat;Drug: Part 2 Adult Alogabat H ...	Hoffmann-La Roche	NULL	Not yet recruiting	5 Years	17 Years	All	56	Phase 2	NULL

First Previous1Next Last